- $2.94bn
- $2.84bn
- $534.53m
Brief: Atricure Files For Mixed Shelf; Size Not Disclosed - SEC Filing
U.S. RESEARCH ROUNDUP-Applovin, Equinix, Hubspot
Brief: Atricure Inc - Outlook FY Revenue Is Projected To Be Approximately $517 Million To $527 Million
AtriCure Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: AtriCure Q4 Adjusted EPS USD -0.08 Vs. IBES Estimate USD -0.23
Brief: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
Brief: AtriCure Q4 Revenue USD 124.3 Million Vs. IBES Estimate USD 119.9 Million
AtriCure Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: AtriCure Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.19
U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley
U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera
AtriCure rises on expanded approval in Europe for its heart device
Brief: AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices
U.S. RESEARCH ROUNDUP- Arista Networks, Penumbra, S&P Global
AtriCure Inc reports results for the quarter ended in June - Earnings Summary
Brief: AtriCure Q2 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.17
AtriCure Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: AtriCure Gets Regulatory Approval To Sell Atriclip Devices In China
AtriCure Inc reports results for the quarter ended in March - Earnings Summary